UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Baidu
BIDU
$38.2B
| $25.9M | 0.02% |
113,454
-8,980
| -7% | -$2.06M |
|
602
SiriusXM
SIRI
$10.2B
| $25.8M | 0.02% |
736,570
-39,878
| -5% | -$1.37M |
|
603
Avery Dennison
AVY
$13.2B
| $25.7M | 0.02% |
495,988
+51,712
| +12% | +$2.46M |
|
|
ARG
604
DELISTED
Airgas Inc
ARG
| $25.7M | 0.02% |
223,372
+2,693
| +1% | +$303K |
|
|
CIT
605
DELISTED
CIT Group Inc.
CIT
| $25.3M | 0.02% |
529,612
+124
| +0% | +$5.89K |
|
606
D.R. Horton
DHI
$41B
| $25.3M | 0.02% |
1,000,616
+11,540
| +1% | +$270K |
|
|
BMR
607
DELISTED
BIOMED REALTY TRUST INC
BMR
| $25.2M | 0.02% |
1,168,083
+148,700
| +15% | +$3.17M |
|
|
ANSS
608
DELISTED
Ansys
ANSS
| $25M | 0.02% |
305,388
-24,666
| -7% | -$1.95M |
|
609
Autoliv
ALV
$9.07B
| $24.8M | 0.02% |
324,405
-4,813
| -1% | -$337K |
|
|
EXAS
610
DELISTED
Exact Sciences
EXAS
| $24.8M | 0.02% |
903,897
+417,500
| +86% | +$10.2M |
|
|
MBT
611
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $24.5M | 0.02% |
3,414,136
-1,911,239
| -36% | -$23M |
|
|
SREV
612
DELISTED
ServiceSource International, Inc.
SREV
| $24.4M | 0.02% |
5,209,078
-315,356
| -6% | -$1.22M |
|
|
WUBA
613
DELISTED
58.com Inc
WUBA
| $24.3M | 0.02% |
584,358
+481,058
| +466% | +$19.8M |
|
614
Fossil Group
FOSL
$348M
| $24.3M | 0.02% |
219,181
-8,269
| -4% | -$864K |
|
615
Leggett & Platt
LEG
$1.37B
| $24.2M | 0.02% |
568,451
+24,076
| +4% | +$948K |
|
616
Helmerich & Payne
HP
$3.41B
| $24.1M | 0.02% |
357,343
-400
| -0.1% | -$31.2K |
|
617
TransDigm Group
TDG
$71.9B
| $24M | 0.02% |
122,458
-653
| -0.5% | -$123K |
|
618
A.O. Smith
AOS
$8.25B
| $24M | 0.02% |
852,304
-100,438
| -11% | -$2.62M |
|
|
ENDP
619
DELISTED
Endo International plc
ENDP
| $24M | 0.02% |
332,417
+4,202
| +1% | +$288K |
|
|
GRMN
620
Garmin
GRMN
$58.8B
| $23.9M | 0.02% |
452,041
-158,230
| -26% | -$8.6M |
|
621
Jefferies Financial Group
JEF
$12.8B
| $23.9M | 0.02% |
1,189,651
+18,674
| +2% | +$385K |
|
622
News Corp Class A
NWSA
$15.1B
| $23.8M | 0.02% |
1,517,699
+128,639
| +9% | +$1.98M |
|
|
TSS
623
DELISTED
Total System Services, Inc.
TSS
| $23.8M | 0.02% |
699,512
-7,795
| -1% | -$252K |
|
624
Fidelity National Financial
FNF
$13.9B
| $23.7M | 0.02% |
990,308
+12,733
| +1% | +$270K |
|
625
Dentsply Sirona
XRAY
$2.83B
| $23.7M | 0.02% |
444,460
-3,041
| -0.7% | -$155K |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.